Edible Garden AG Incorporated (EDBL) is a controlled environment agriculture (CEA) company that grows organic herbs and fresh produce and is expanding into shelf-stable and ready-to-drink nutrition under its Farm-to-Formula platform. It is a stock, but it has unusually thin analyst coverage: only one current, attributable target could be verified. In June 2026, Maxim Group analyst Anthony Vendetti lowered the firm's price target to $1.00, split-adjusted from $80, while keeping a Buy rating, citing a favorable view of the transition toward ready-to-drink protein and nutrition but reducing the target for equity dilution and execution risk.
Because a single analyst does not form a meaningful consensus, the $1 central target here is best understood as a fallback reference from public discussion rather than an official consensus. It is reinforced by a second, independent anchor: Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00. Several data aggregators still display higher, stale figures that predate the company's 1-for-45 reverse stock split effective July 13, 2026; those split-unadjusted numbers are not reliable and are excluded.
The shares last traded near $0.70, within a 52-week range whose low sits around $0.66. Reaching $1.00 therefore implies a gain of roughly 43%, a substantial move. The path would require the stock to hold above its recent lows and reclaim the $1.00 level that doubles as a regulatory threshold. The company reported roughly $13.8 million in trailing revenue against a net loss near $24 million, with about $658,000 in cash and a debt-to-equity ratio above 260%. A move toward the target would likely depend on evidence that the nutrition-focused strategy can improve margins and slow cash burn, alongside sustained compliance with Nasdaq's listing standards.
Management has described the Webster City facility's expansion into ready-to-drink manufacturing and a push into higher-margin, shelf-stable nutrition categories as central to its strategy. Regaining Nasdaq compliance in September 2026 removed near-term delisting uncertainty, and the company's products reach thousands of retail locations. The single Buy rating, the $1 analyst reference point, and the psychological significance of $1.00 itself could also concentrate investor attention at that level.
The risks are substantial. The company is unprofitable, holds limited cash, and carries heavy leverage, leaving little room for execution missteps. Repeated reverse stock splits signal ongoing dilution and balance-sheet strain, and EPS (earnings per share) remains deeply negative, though warrant-related accounting distorts the headline figure. Nasdaq has placed the company under a Mandatory Panel Monitor for one year from late August 2026, meaning any renewed noncompliance with the bid price rule could trigger an expedited delisting process. Weak consumer demand, competitive pressure in packaged food, and macro-driven pressure on small-cap equities could all weigh on sentiment.
From a technical standpoint, $1.00 is the pivotal level: it functions as both a psychological resistance level and the Nasdaq compliance threshold. The recent 52-week low near $0.66 acts as the nearest meaningful support level. A sustained hold above $1.00 would be a structurally significant development, while a break below $0.66 would reopen delisting concerns and weaken the case for the target.
The single analyst target carries an implied research horizon of roughly 12 months, though no firm timeline is guaranteed. Investors should watch the company's next earnings report (estimated for mid-November 2026), any guidance on revenue growth and cash burn, further analyst revisions, and Nasdaq monitoring updates through late November 2026. The Mandatory Panel Monitor period and any new financing or capital raises will also be important signals.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a thinly covered, volatile micro-cap like EDBL, such tools can help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual screening. Traders seeking an edge may want to explore the platform's signals as part of a broader research process.
The $1 target for Edible Garden is a fallback reference drawn from a single current analyst target and Nasdaq's minimum bid price rule, not a broad analyst consensus. With the stock near $0.70, the required upside of roughly 43% is substantial. The strongest supports are the strategic pivot toward nutrition products and regained listing compliance, while persistent losses, tight cash, dilution, and delisting risk are the principal obstacles. Because coverage is so thin, the figure should be read as a reference point rather than a forecast, and investors should monitor earnings, cash flow, and Nasdaq oversight closely.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that EDBL and AQB have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDBL and AQB's prices will move in lockstep.
| Ticker / NAME | Correlation To EDBL | 1D Price Change % | ||
|---|---|---|---|---|
| EDBL | 100% | +1.01% | ||
| AQB - EDBL | 22% Poorly correlated | -2.83% | ||
| AFRI - EDBL | 11% Poorly correlated | -1.17% | ||
| DOLE - EDBL | 9% Poorly correlated | +0.57% | ||
| CHSCM - EDBL | 9% Poorly correlated | -1.12% | ||
| DMC - EDBL | 8% Poorly correlated | -0.72% | ||
More | ||||